- Home
- CSWI vs CORT Comparison
CSWI vs CORT Comparison
Compare CSWI & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSWI
- CORT
- Stock Information
- Founded
- CSWI 2014
- CORT 1998
- Country
- CSWI United States
- CORT United States
- Employees
- CSWI N/A
- CORT N/A
- Industry
- CSWI Home Furnishings
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- CSWI Industrials
- CORT Health Care
- Exchange
- CSWI Nasdaq
- CORT Nasdaq
- Market Cap
- CSWI 6.6B
- CORT 5.6B
- IPO Year
- CSWI N/A
- CORT N/A
- Fundamental
- Price
- CSWI $396.86
- CORT $61.11
- Analyst Decision
- CSWI Buy
- CORT Strong Buy
- Analyst Count
- CSWI 4
- CORT 4
- Target Price
- CSWI $404.67
- CORT $75.25
- AVG Volume (30 Days)
- CSWI 89.9K
- CORT 773.5K
- Earning Date
- CSWI 01-30-2025
- CORT 02-13-2025
- Dividend Yield
- CSWI 0.24%
- CORT N/A
- EPS Growth
- CSWI 10.71
- CORT 57.97
- EPS
- CSWI 7.36
- CORT 1.26
- Revenue
- CSWI $839,930,000.00
- CORT $628,555,000.00
- Revenue This Year
- CSWI $12.77
- CORT $46.29
- Revenue Next Year
- CSWI $7.51
- CORT $17.09
- P/E Ratio
- CSWI $53.00
- CORT $48.47
- Revenue Growth
- CSWI 8.55
- CORT 39.67
- 52 Week Low
- CSWI $203.83
- CORT $20.84
- 52 Week High
- CSWI $436.50
- CORT $62.22
- Technical
- Relative Strength Index (RSI)
- CSWI 67.05
- CORT 70.63
- Support Level
- CSWI $348.34
- CORT $49.00
- Resistance Level
- CSWI $361.83
- CORT $52.17
- Average True Range (ATR)
- CSWI 8.57
- CORT 2.04
- MACD
- CSWI 5.71
- CORT 0.97
- Stochastic Oscillator
- CSWI 92.30
- CORT 98.94
About CSWI CSW Industrials Inc.
CSW Industrials Inc is a diversified industrial growth company with well-established, scalable platforms and domain expertise across three segments, Contractor Solutions, Engineered Building Solutions, and Specialized Reliability Solutions. The company's Contractor Solutions segment involves manufacturing efficient and performance-enhancing products for residential and commercial HVAC/R and plumbing applications, which are designed for professional end-use customers. Majority of the company revenue is generated from Contractor Solutions segment from U.S. markets.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.